Positron emission tomography (PET): An update on applications in breast cancer

Richard L. Wahl

Research output: Contribution to journalArticle

Abstract

Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.

Original languageEnglish (US)
Pages (from-to)165-175
Number of pages11
JournalBreast Disease
Volume10
Issue number3-4
StatePublished - Aug 1998
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Breast Neoplasms
Neoplasm Metastasis
Deoxyglucose
Glucose
Research
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Positron emission tomography (PET) : An update on applications in breast cancer. / Wahl, Richard L.

In: Breast Disease, Vol. 10, No. 3-4, 08.1998, p. 165-175.

Research output: Contribution to journalArticle

Wahl, Richard L. / Positron emission tomography (PET) : An update on applications in breast cancer. In: Breast Disease. 1998 ; Vol. 10, No. 3-4. pp. 165-175.
@article{04a16e82e216490bb3b2ca028824d715,
title = "Positron emission tomography (PET): An update on applications in breast cancer",
abstract = "Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.",
author = "Wahl, {Richard L.}",
year = "1998",
month = "8",
language = "English (US)",
volume = "10",
pages = "165--175",
journal = "Breast Disease",
issn = "0888-6008",
publisher = "IOS Press",
number = "3-4",

}

TY - JOUR

T1 - Positron emission tomography (PET)

T2 - An update on applications in breast cancer

AU - Wahl, Richard L.

PY - 1998/8

Y1 - 1998/8

N2 - Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.

AB - Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.

UR - http://www.scopus.com/inward/record.url?scp=0031656010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031656010&partnerID=8YFLogxK

M3 - Article

C2 - 15687572

AN - SCOPUS:0031656010

VL - 10

SP - 165

EP - 175

JO - Breast Disease

JF - Breast Disease

SN - 0888-6008

IS - 3-4

ER -